Skip to main content

Table 1 Pre and postoperative pituitary function surveys

From: Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review

 

FT4 (pmol/L)

FT3 (pmol/L)

TSH (mIU/L)

TGAb (IU/mL)

TPOAb (IU/mL)

TG (ug/L)

TRAb (IU/L)

SHBG (nmol/L)

GH (ug/L)

IGF-1 (ng/mL)

PRL (ng/mL)

Pre-hospital

           

 D1 (MMI)

10.81

25.8

8.6

 D23

7.97

19.98

10.49

 D30

9.4

18.04

14.76

Pre-operation

           

 D1

8.99

19.78

12.268

271.7

455.91

4.02

1.13

93.3

4.82

661

19.03

 D10 (OCT)

13.58

31.95

7.715

 D12

7.78

25.95

1.208

1.15

354

9.61

 D15

3.81

14.62

0.282

 D18

3.33

13.03

0.299

Post-operation

           

 D1

2.58

14.87

0.044

2.1

268

19.26

 D3

3.02

12.77

0.097

0.31

211

20.67

 D7

2.75

9.9

0.299

0.16

274

24.06

 1Mon

4.2

11.09

1.187

305.8

251.75

5.94

17.48

5.38

231

17.48

 3Mon-a

8.15

22.85

0.187

285.6

735.26

20.35

2.93

69

0.65

299

12.82

 3Mon-b

4.55

14.11

0.242

303.3

848.25

5.74

1.6

 4Mon

2.92

6.41

6.772

330.6

> 1000

1.44

2.73

 6mon (L-T4)

4.08

10.36

4.154

328.3

929.41

1.9

1.02

56

0.22

175

12.65

  1. Abbreviation, MMI methimazole, OCT octreotide, L-T4 levothyroxine sodium tablets; hormone (reference range): FT3 free triiodothyronine (3.1–6.89 pmol/L), FT4 free thyroxine (11–22 pmol/L), GH growth hormone (0–3μg/L), IGF-1 insulin-like growth factor-1 (115–307 ng/mL), PRL prolactin (5.18–26.53 ng/mL), SHBG sex hormone-binding globulin (34.3–147 nmol/L), TSH thyroid-stimulating hormone (0.27–4.2mIU/L), TGAb thyroglobulin antibody (0–115 IU/mL), TPOAb thyroid peroxidase antibody (0–5.61 IU/mL), TRAb thyrotropin receptor antibody (0–1.75 IU/L), TG thyroglobulin (3.5–77μg/L)